Patrick joined Taylor Vinters in May 2005. He read law at the University of London. Patrick is a transactional technology lawyer specialising in the exploitation of intellectual property, in particular in the life sciences sector. He has both Swiss and English passports and speaks fluent French. Patrick recently advised Microbiotica on its strategic collaboration with Genentech for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline, utilising Microbiotica’s leading gut microbiome Reference Genome Database and Culture Collection. Microbiotica to receive up to $534 million in upfront and milestone payments He was ranked in the 'Hall of Fame' in Legal 500 during 2018 for consistently being top ranked by clients as an IP specialist.